Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine

Go back to Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.89 +0.33 (3.86%)
Previous Close $8.56    52 Week High $9.23 
Open $8.54    52 Week Low $1.16 
Day High $8.90    P/E N/A 
Day Low $8.45    EPS $-0.30 
Volume 1,904,519       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.89 +0.33 (3.86%)
Previous Close $8.56    52 Week High $9.23 
Open $8.54    52 Week Low $1.16 
Day High $8.90    P/E N/A 
Day Low $8.45    EPS $-0.30 
Volume 1,904,519